General. Identification. Loire-Atlantique/Vendée cancer registry (registre. Detailed name. qualifié)

Similar documents
HAUT-RHIN CANCER REGISTRY

French registry of pleural mesothelioma cases

RIC-Mel Network - Network for Research and Clinical Investigation on Melanoma - French national cohort of

Head : Momas Isabelle, EA 4064 UNIVERSITE PARIS DESCARTES ET MAIRIE DE PARIS CELLULE «COHORTE»

ANRS CO12 CIRVIR - Prospective cohort involving patients with viral cirrhosis B and C

People in Ile-de-France. Accord CNIL

General. Identification. Etude de PROXimologie dans l'asthme persistant. Detailed name. sévère

arthrosis and coxarthrosis) in the general population and in those treated by spa therapy

ESEMeD/MHEDEA The European Study of the Epidemiology of Mental Disorders/Mental Health Disability : a

General French Cancer Registries The example of the Cancer Registry of Doubs and Belfort Territory

Général. Identification

Planning a Community based Cancer Registry. Cancer Registration: Principles and Methods Edited by Jensen O. M. et al IARC 1991; pages

Overview of 2013 Hong Kong Cancer Statistics

Overview of 2010 Hong Kong Cancer Statistics

Overview of 2009 Hong Kong Cancer Statistics

Summary Report Report on Cancer Statistics in Alberta. February Surveillance and Health Status Assessment Cancer Surveillance

2012 Report on Cancer Statistics in Alberta

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1995

THE BURDEN OF CANCER IN NEBRASKA: RECENT INCIDENCE AND MORTALITY DATA

Summary Report Report on Cancer Statistics in Alberta. December Cancer Care. Cancer Surveillance

IJC International Journal of Cancer

Cancer incidence in the Republic of Mauritius- 5 Years Review 1997 to 2001

Cancer in the Northern Territory :

Overview of Hong Kong Cancer Statistics of 2015

Cancer Services Performance Indicators. Round Report

COUNCIL RECOMMENDATION of 2 December 2003 on cancer screening (2003/878/EC)

Cancer in the Arabian Gulf Kingdom of Bahrain ( ) Fayek A Alhilli, PhD (Path)* Nagalla S Das, MD*

Report on Cancer Statistics in Alberta. Melanoma of the Skin

ENCR Call for Data 21 May 2010

Downloaded from:

Statement of Organization, Functions, and Delegations of Authority. Part C (Centers for Disease Control and Prevention) of the Statement of

S Congenital Heart Futures Act (Introduced in Senate - IS) 111th CONGRESS 1st Session S. 621 IN THE SENATE OF THE UNITED STATES.

Information Services Division NHS National Services Scotland

Consumer Participation Strategy

A Review of Medical Malpractice Claims from the CRICO Comparative Benchmarking System

CASEFINDING. KCR Abstractor s Training

Title 1 Descriptive title identifying the study design, population, interventions, and, if applicable, trial acronym

Report on Cancer Statistics in Alberta. Kidney Cancer

First Interim Report to the European Commission DG-SANCO for: Grant Agreement No.: (790655) EAIS. December Annex 2

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Welcome ACoS Brainstorming Webinar

RHODE ISLAND CANCER PREVENTION AND CONTROL

Extract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study

Information Services Division NHS National Services Scotland

A Time- and Resource-Efficient Method for Annually Auditing All Reporting Hospitals in Your State: the Inpatient & Outpatient Hospital Discharge Files

PROJECT INFORMATION DOCUMENT (PID) APPRAISAL STAGE Report No.: PIDA Project Name. Region. Country. Sector(s) Health (100%) Theme(s)

Information Services Division NHS National Services Scotland

Lynch Syndrome: A Public Health Approach

Report on Cancer Statistics in Alberta. Breast Cancer

We re on the Web! Visit us at www2.kumc.edu/kcr

Mississippi State Department of Health, Health Services / Office of Health Data and Research

Hazelinks - Cancer incidence analysis (First data extraction)

South Australia s recovery arrangements. Ronnie Faggotter Director, State Recovery Office SA April 2017

California. Maternal and Child Health Block Grant 2018

Access Points: Frequently Asked Questions 15 June 2016

Global surveillance of cancer survival

United Kingdom and Ireland Association of Cancer Registries (UKIACR) Performance Indicators 2018 report

Pharmacovigilance Methods and Post-Authorisation Safety Studies

I.2 CNExT This section was software specific and deleted in 2008.

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Estimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004

Novo Nordisk Pharma AG Methodology Note - reporting year 2016 ( Methodology )

CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996

Contents [HEALTH PROFILES - QUARTERLY UPDATE BRIEFING AUGUST 2016] M.Foxcroft. Performance & Intelligence Team

NHS. Northern and Yorkshire Cancer Registry and Information Service

CONGENITAL HEART PUBLIC HEALTH CONSORTIUM

Changes to the National Diabetes Services Scheme (NDSS)

Implementation of nation-wide molecular testing in oncology in the French Health care system : quality assurance issues & challenges

Cancers and agriculture in France, what are the current and expected short term lessons from the AGRICAN (AGRIculture & CANcer) cohort

Incidence of Cancers Associated with Modifiable Risk Factors and Late Stage Diagnoses for Cancers Amenable to Screening Idaho

Global database on the Implementation of Nutrition Action (GINA)

Table Of Content. Annex 1: Conference report... 7 Annual project reports (URL)... 7 Original Full Information (Dec 2008)... 7.

Metropolitan and Micropolitan Statistical Area Cancer Incidence: Late Stage Diagnoses for Cancers Amenable to Screening, Idaho

Suicides increased in 2014

Cancer Survival in Wales, Goroesi Cancr yng Nghymru,

What is the Impact of Cancer on African Americans in Indiana? Average number of cases per year. Rate per 100,000. Rate per 100,000 people*

TARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.

Survival in Teenagers and Young. Adults with Cancer in the UK

ALL CANCER (EXCLUDING NMSC)

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

COMMUNITY PARTNERS MEETING

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Florida Cancer Data System STAT File Documentation Version 2019

KEY QUESTIONS What outcome do you want to achieve for mental health in Scotland? What specific steps can be taken to achieve change?

EUROCHIP-II FINAL SCIENTIFIC REPORT ANNEX 08 REPORT OF ESTONIA

North American Association of Central Cancer Registries (NAACCR)

Epidemiology in Texas 2006 Annual Report. Cancer

THE BURDEN OF HEALTH AND DISEASE IN SOUTH AFRICA

5.2 Main causes of death Brighton & Hove JSNA 2013

The principles of the Higher Education and Research Reform Bill 2014, and related matters Submission 64

Isaacus Digital Health HUB. Health Tuesday

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health

RACGP Immunisation Position Paper

Summary of current policy drivers and national practice overview

Cancer Dispari,es in Indiana

We re on the Web! Visit us at VOLUME 19 ISSUE 1. January 2015

Cancer in Ontario. 1 in 2. Ontarians will develop cancer in their lifetime. 1 in 4. Ontarians will die from cancer

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Rare cancers Medical oncologist Point of View

Transcription:

EPIC-PL - Loire-Atlantique/Vendée cancer registry (registre qualifié) Head : Molinié Florence Last update : 09/08/2017 Version : 1 ID : 224 General Identification Detailed name Sign or acronym CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation Loire-Atlantique/Vendée cancer registry (registre qualifié) EPIC-PL 900234 General Aspects Medical area Health determinants Cancer research Geography Healthcare system and access to health care services Social and psychosocial factors Collaborations Participation in projects, networks and consortia Details Others Yes Francim network, Grell network, European network of cancer registries, inernational association of cancer registries EUROCARE, CONCORD, HIGHCARE, SUDCAN studies Funding Funding status Details Mixed Financial support of the registry come from SantéPublique France, INCa, Conseil Régional des Pays de la Loire, ARS Pays de la Loire, Ligue contre le Cancer de Loire-Atlantique et Vendée, CHD de La Roche sur Yon.

Governance of the database Sponsor(s) or organisation(s) responsible Organisation status Association EPIC-PL Private Scientific investigator(s) (Contact) Name of the director Surname Address Molinié Florence Registre des cancers, Plateau des écoles, 50 route de St Sébastien, 44093 NANTES Cedex 1, FRANCE Phone +33 (0)2 40 84 69 81 Email Organization fmolinie@chu-nantes.fr Loire-Atlantique et Vendée Cancer Registry Additional contact Main features Type of database Type of database Additional information regarding sample selection. Morbidity registers Selection of subjects having the required inclusion criteria (see below). Several sources are used to identify cases: - Anatomopathology laboratories - Hematological cytology laboratories - Medical information departments - Health Insurance Funds - Private-practicing and hospital physicians - Management structure of organized breast cancer screening - National registry of solid tumors in children, registry of hematological malignancies in children - specific cancer medical record (summary) Database objective The registry carries out a continuous and exhaustive collection of all new cancer diagnoses in the general population living in a given département. It has the twofold objective of

Main objective monitoring the cancer risk and of conducting research on cancer. Objectives of the Registry in terms of public health: - Participate in the epidemiological surveillance of cancers at local and national level under the Francim network by publishing incidence indicators by cancer location, gender, age and year of diagnosis. - Evaluate primary and secondary prevention initiatives (organized cancer screening), patient treatment and healthcare needs in the general population. The EPIC-PL undertakes a wide range of projects in liaison with local and national partners. The main themes are: evaluation of treatment practices and research on social inequalities Only a population based registry provides precise and exhaustive information on cancer incidence in the context of the French healthcare system. It is also necessary for evaluating the effectiveness of prevention and screening programs as well as cancer care streams in the general population - with no selection bias. Inclusion criteria All primitive invasive malignant tumors diagnosed in people living in these two départements at the time of diagnosis, irrespective of their treatment location. The following are also recorded: - in situ breast cancers, cervix cancers, colorectal cancers and in situ melanomas - non-invasive tumors of the urinary tract and central nervous system and borderline tumors of the ovary. The following are not recorded: - stratum basale skin cancers (only recorded in the Vendée from 1997 to 1999) Population type Age Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) Adulthood (19 to 24 years) Adulthood (25 to 44 years) Adulthood (45 to 64 years) Elderly (65 to 79 years) Great age (80 years and more)

Population covered Pathology Gender Geography area French regions covered by the database Detail of the geography area Sick population II - Neoplasms Male Woman Departmental Pays de la Loire Loire-Atlantique and Vendée Data collection Dates Date of first collection (YYYY or MM/YYYY) Date of last collection (YYYY or MM/YYYY) 1991 2015 Size of the database Size of the database (number of individuals) Details of the number of individuals Greater than 20 000 individuals >150 000 in 2017 Data Database activity Type of data collected Clinical data (detail) Paraclinical data (detail) Biological data (detail) Administrative data (detail) Presence of a biobank Data collection completed Clinical data Paraclinical data Biological data Administrative data Direct physical measures Any additional examination providing information for tumor coding Any additional examination providing information for tumor coding Identification data No

Health parameters studied Health event/morbidity Health event/mortality Procedures Data collection method Active or passive collection (CNIL authorization), depending on source:- Systematic requests for anatomocytopathology reports- Annual systematic requests for PMSI files (Standardized selection procedure) or lists comprising more items, such as the Permanent Cancer Survey conducted by the cancer prevention centers - Annual systematic requests for files of patients diagnosed with one of the chronic diseases from the ALD 30 list.- Spontaneous passive declaration and active reminder posted to physicians- Active search for regular complementary information in medical records. Classifications used ICD-O -3 Participant monitoring Details on monitoring of participants Links to administrative sources Yes Cases are followed up at regular intervals with the following information gathered:- Date of last news - Vital status at last news No Promotion and access Promotion Link to the document Description Link to the document Description http://www.santepaysdelaloire.com/registre-descancers/articles/publications-scientifiques publications listed on the registry website https://www.ncbi.nlm.nih.gov/pubmed/? term=molinie+f pubmed publications Access Terms of data access (charter for data provision, format of data, availability delay) Incidence data is available in aggregate form, by cancer location, year, gender and age. This data is published at regular intervals at local and national level (see Find out more). Regional documents can be downloaded on the registry's website. The data recorded in the Registry may be used

for specific research. Project requests are analyzed by the Registry's Strategic and Scientific Advisory Board. The arrangements for cooperation must be defined. Access to aggregated data Access to individual data Free access Access on specific project only